CureVac Secures an Additional $29.5 Million From Two New Investors

08.11.2016 | Baden-Württembergische Versorgungsanstalt für Ärzte, Zahnärzte und Tierärzte and Landeskreditbank Baden-Württemberg invest in CureVac‘s development of ...

CureVac Receives Broad Patent for RNAntibody® Technology

08.11.2016 | CureVac AG today announced that it has been granted a patent (patent No. EP2101823) by the European Patent Office providing broad patent protection for the Company’s ...

Demo Day – just the start

18.10.2016 | Participants in 100-day MedTech Startup School 2016 present their ideas for founding new businesses ...